<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04006418</url>
  </required_header>
  <id_info>
    <org_study_id>MRCTA,ECFAH OF FMU[2019]194</org_study_id>
    <nct_id>NCT04006418</nct_id>
  </id_info>
  <brief_title>A Registered Cohort Study on Spastic Paraplegia</brief_title>
  <official_title>A Registered Cohort Study on Spastic Paraplegia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wan-Jin Chen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Fujian Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the clinical spectrum and natural progression of
      Hereditary Spastic Paraplegias(HSP) and related disorders in a prospective multicenter
      natural history study, to assess the clinical, genetic and epigenetic features of patients
      with Spastic Paraplegias to optimize clinicalmanagement..
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 2049</completion_date>
  <primary_completion_date type="Anticipated">December 2039</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Spastic Paraplegia Rating Scale (SPRS)</measure>
    <time_frame>6 months</time_frame>
    <description>Disease severity will be assessed by application of the Spastic Paraplegia Rating Scale (SPRS), a clinical rating scale measuring disease severity in Hereditary Spastic Paraplegia (Schule et al. Neurology 2006). The SPRS contains 13 items, each ranging from 0 to 4 points. The total score is calculated as the sum of all items, yielding a range for the total score between 0 and 52. Hereby, higher SPRS total scores indicate more severe disease.</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Spastic Paraplegia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed in hosipital and their's family
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with the clinical diagnosis of spastic paraplegia

          -  Clinical diagnosis of patients with spastic paraplegia

          -  Unrelated healthy controls

        Exclusion Criteria:

          -  Decline to participate.

          -  There are serious interferences with individual participation and adherence to the
             research protocol, including but not limited to neurological, psychological, and/or
             medical conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yi Lin, MD,PhD</last_name>
    <phone>+13615039153</phone>
    <email>wanjinchen75@fjmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wan-Jin Chen, MD,PhD</last_name>
    <phone>+1386061359</phone>
    <phone_ext>+1386061359</phone_ext>
    <email>wanjinchen75@fjmu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Affiliated Hospital Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wan-Jian Chen, MD, PhD</last_name>
      <email>wanjinchen75@fjmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Wan-Jin Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ning Wang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>September 21, 2019</last_update_submitted>
  <last_update_submitted_qc>September 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Fujian Medical University</investigator_affiliation>
    <investigator_full_name>Wan-Jin Chen</investigator_full_name>
    <investigator_title>The Vice-Director for the Department of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Paraplegia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

